Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema The American Journal of Managed Care® (AJMC®) Source link
Eczema treatment success sparks call for urgent policy change Region Canberra Source link
Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD Dermatology Times Source link
Top 5 Articles of the Week: April 12-17 Dermatology Times Source link